The 13th International Pharma Convention 2025 brings together industry leaders, innovators, and experts to discuss the future of Pakistanโs pharmaceutical industry, focusing on compliance, capacity, and global connectivity.
๐๐ฎ๐๐ฌ๐ญ๐ฌ ๐จ๐ ๐๐จ๐ง๐จ๐ซ:
Mr. Muhammad Kamran Nasir โ Sr. Vice Chairman PPMA
Mr. Athar Nazir Sheikh โ Vice Chairman PPMA
Mr. Mutti ur Rehman โ Chairman South Zone, PPMA
๐๐๐ฅ๐๐จ๐ฆ๐ ๐๐จ๐ญ๐:
Dr. Sheikh Kaiser Waheed โ Managing Director, Medisure Laboratories (Pvt.) Ltd.
๐๐๐ฒ ๐๐ฉ๐๐๐ค๐๐ซ๐ฌ:
Mr. Rafael Beaus โ Global Consultancy Manager, Syntagon Telstar Technologies
Mr. Hasan Faraz โ Managing Director, Maersk Pakistan
Mr. Sultan Ghani โ International Pharmaceutical Consultant
Mr. Sunil Doshi โ Managing Director, PharmSoi Group
Panel Discussion: Transforming Pakistanโs Pharma: Compliance, Capacity and Connectivity to the World
๐๐จ๐๐๐ซ๐๐ญ๐จ๐ซ:
Dr. Syed Azizur Rab โ CEO, Greenstar Social Marketing
๐๐๐ง๐๐ฅ๐ข๐ฌ๐ญ๐ฌ:
Mr. Muhammad Kamran Nasir โ Managing Director & CEO, AGP Limited
Mr. Arshad Raheem โ Consultant, Pharma Exports, TDAP
Mr. Tauqeer Ul Haq โ Managing Director, Sante (Pvt) Ltd.
Dr. Munir Anwar โ Director Operations, Atco Laboratories
Dr. Shahnawaz Sajid โ CEO, HighQ Pharmaceutical
๐๐๐ฉ๐ซ๐๐ฌ๐๐ง๐ญ๐๐ญ๐ข๐ฏ๐๐ฌ ๐๐ซ๐จ๐ฆ ๐๐๐๐๐๐ ๐๐ง๐ ๐๐๐จ๐ฆ๐ฆ๐๐ซ๐๐ ๐๐๐ญ๐๐ฐ๐๐ฒ ๐๐๐ค๐ข๐ฌ๐ญ๐๐ง (๐๐ฏ๐ญ.) ๐๐ญ๐.
This convention highlights global pharma trends, compliance standards, export potential, and the role of innovation in shaping Pakistanโs pharmaceutical industry.
